Julia Meyerovich
she/her/hers
Research Assistant 1, HSSDownloadHi-Res Photo
Cards
Pain and Addiction Interaction Neuroscience (PAIN) Lab
The mission of the PAIN Lab is to pioneer new approaches for understanding and treating chronic pain and substance use disorders.
Contact Info
About
Copy Link
Titles
Research Assistant 1, HSS
Biography
Julia Meyerovich is the laboratory manager for the PAIN Lab at the Yale University Department of Psychiatry. She oversees all research studies and manages the laboratory staff within the PAIN Lab. Julia is actively involved in the development, training, and implementation of research protocols, as well as data management. She works closely with the PAIN Lab team to ensure that all research projects adhere to protocol, schedule, budget, and clinical standards. Julia has a particular interest in the role of psychedelics in the context of pain and addiction.
Last Updated on May 15, 2026.
Departments & Organizations
- Pain and Addiction Interaction Neurosciences (PAIN) Lab
Education & Training
- MA
- Southern Connecticut State University, Psychology
- BA
- Southern Connecticut State University, Psychology
Research
Copy Link
Overview
Medical Research Interests
Chronic Pain; Psychotropic Drugs; Substance-Related Disorders
ORCID
0000-0003-4104-6964Pain and Addiction Interaction Neuroscience (PAIN) Lab
The mission of the PAIN Lab is to pioneer new approaches for understanding and treating chronic pain and substance use disorders.
View Lab Website
Research at a Glance
Publications Timeline
A big-picture view of Julia Meyerovich's research output by year.
Yale Co-Authors
Frequent collaborators of Julia Meyerovich's published research.
5Publications
28Citations
Mehmet Sofuoglu, MD, PhD
Joao P. De Aquino, MD
Brian Pittman
Noah Wolkowicz
R. Ross MacLean, PhD
Elise DeVito, PhD
Publications
2025
The Role of Childhood Trauma in Chronic Pain and Substance Use Among Individuals Receiving Methadone Treatment for Opioid Use Disorder.
Costa G, Ra J, Meyerovich J, Pittman B, C Nunes J, De Aquino J. The Role of Childhood Trauma in Chronic Pain and Substance Use Among Individuals Receiving Methadone Treatment for Opioid Use Disorder. Journal Of Addiction Medicine 2025 PMID: 40728216, DOI: 10.1097/adm.0000000000001553.Peer-Reviewed Original ResearchConceptsOpioid use disorderChildhood Trauma QuestionnaireChildhood traumaSubstance useCannabis initiationUse disorderBrief Pain InventoryEmotional abuseAge of cannabis initiationPain severityChronic painHigher childhood trauma scoresHistory of childhood traumaLikelihood of cannabis useLevels of emotional abuseChildhood trauma exposureChildhood trauma scoresTrauma-focused assessmentAlcohol consumptionHigher alcohol useOpioid use disorder treatment programsTrauma exposureTrauma QuestionnaireCannabis useTrauma subscales
2024
The relationship of pain intensity and opioid craving with delayed methadone dose: A preliminary study of individuals with opioid use disorder
MacLean R, Spinola S, Pittman B, Meyerovich J, Szollosy S, Wolkowicz N, Minnix S, Sofuoglu M. The relationship of pain intensity and opioid craving with delayed methadone dose: A preliminary study of individuals with opioid use disorder. British Journal Of Clinical Pharmacology 2024, 90: 2977-2984. PMID: 38439592, PMCID: PMC11613043, DOI: 10.1111/bcp.16027.Peer-Reviewed Original ResearchCitationsAltmetricConceptsCold pressor testMethadone doseExperience of painOpioid cravingMethadone conditionTime course of painRelationship of pain intensityDose conditionsCourse of painAssessment of painOpioid use disorderCross-over designPain intensityPain thresholdIncreased riskPainStudy visitsPressor testDelayed dosesUse disorderCravingOpioidMethadone treatmentDoseMethadone
2023
Delta‐9‐tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within‐subject, randomized, placebo‐controlled laboratory study
De Aquino J, Meyerovich J, Xie C, Ranganathan M, Compton P, Pittman B, Rogan M, Sofuoglu M. Delta‐9‐tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within‐subject, randomized, placebo‐controlled laboratory study. Addiction Biology 2023, 28: e13317. PMID: 37644897, PMCID: PMC10468603, DOI: 10.1111/adb.13317.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOpioid use disorderOpioid agonist therapyAgonist therapyMethadone dosesMethadone therapyPain sensitivityUse disordersPlacebo-controlled laboratory studySynergistic antinociceptive effectCognitive adverse effectsSingle oral dosesRisk-benefit profilePain sensitivity measuresCannabinoid receptor systemAntinociceptive effectTHC doseOral dosesOpioid agonistsAcute effectsCannabinoid agonistsPreclinical studiesAbuse potentialOpioid crisisTherapyReceptor systemIntegrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results
MacLean R, Heapy A, Waters A, Wolkowicz N, Szollosy S, Meyerovich J, Sofuoglu M. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results. Drug And Alcohol Dependence 2023, 246: 109857. PMID: 37004461, PMCID: PMC10189744, DOI: 10.1016/j.drugalcdep.2023.109857.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsTrial-level bias scoresOpioid cuesAB taskCognitive bias modification taskAttentional bias taskCognitive bias modificationComputer-based tasksPreliminary efficacyOpioid use disorderCurrent studyBias modificationBias taskBias scoresModification tasksCBM groupCBM tasksChronic painAcceptability measuresControl conditionTaskUse disordersClinical careCuesTime interactionParticipants
2022
Development of pulsed intravenous nicotine infusions as a model for inhaled nicotine in humans
De Aquino JP, DeVito EE, Xie C, Meyerovich J, Parida S, Gueorguieva R, Sofuoglu M. Development of pulsed intravenous nicotine infusions as a model for inhaled nicotine in humans. Psychopharmacology 2022, 239: 2809-2818. PMID: 35554617, DOI: 10.1007/s00213-022-06162-0.Peer-Reviewed Original ResearchCitationsAltmetric
News
Copy Link
News
- July 29, 2025Source: Journal of Addiction Medicine
The Role of Childhood Trauma in Chronic Pain and Substance Use Among Individuals Receiving Methadone Treatment for Opioid Use Disorder
- August 01, 2023Source: Addiction Biology
Delta-9-Tetrahydrocannabinol Modulates Pain Sensitivity Among People Receiving Opioid Agonist Therapy
Get In Touch
Copy Link
Contacts
Locations
Clinical Neuroscience Research Unit
Academic Office
Connecticut Mental Health Center
34 Park Street, Fl 3, Rm 333A
New Haven, CT 06519
VA Connecticut Healthcare
Lab
950 Campbell Avenue, Wing Building 36
West Haven, CT 06516